Clinical Trial Update: Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Niraparib, TSR-022, Bevacizumab, and TSR-042 with platinum-based chemotherapy in patients with advanced or metastatic solid tumors, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Dostarlimab (dostarlimab)
• Niraparib (Niraparib)
• TSR-022

Snippet

Sponsor: Tesaro, Inc. | Conditions: Neoplasms, Metastatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-05-10